KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Receivables: 2009-2025

Historic Receivables for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to $1.5 billion.

  • Quest Diagnostics' Receivables rose 5.81% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 billion, marking a year-over-year increase of 6.81%. This contributed to the annual value of $1.3 billion for FY2024, which is 7.77% up from last year.
  • Per Quest Diagnostics' latest filing, its Receivables stood at $1.5 billion for Q3 2025, which was up 2.61% from $1.4 billion recorded in Q2 2025.
  • In the past 5 years, Quest Diagnostics' Receivables ranged from a high of $1.5 billion in Q3 2021 and a low of $1.2 billion during Q4 2022.
  • Its 3-year average for Receivables is $1.3 billion, with a median of $1.3 billion in 2024.
  • In the last 5 years, Quest Diagnostics' Receivables spiked by 41.97% in 2021 and then dropped by 16.90% in 2022.
  • Quarterly analysis of 5 years shows Quest Diagnostics' Receivables stood at $1.4 billion in 2021, then decreased by 16.90% to $1.2 billion in 2022, then increased by 1.26% to $1.2 billion in 2023, then increased by 7.77% to $1.3 billion in 2024, then increased by 5.81% to $1.5 billion in 2025.
  • Its last three reported values are $1.5 billion in Q3 2025, $1.4 billion for Q2 2025, and $1.4 billion during Q1 2025.